AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Significant Growth in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totaling 968,046 shares, an increase of 238.1% from the July 15th total of 286,322 shares. Based on an average trading volume of 799,324 shares, the days-to-cover ratio is presently 1.2 days. Approximately 3.8% of the shares of the stock are short sold.

Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund

Several institutional investors and hedge funds have recently added to or reduced their stakes in BTAL. Crescent Grove Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund in the first quarter worth approximately $6,614,000. Advisory Services Network LLC boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% during the 4th quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock worth $4,743,000 after acquiring an additional 314,565 shares in the last quarter. PMV Capital Advisers LLC boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% during the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after acquiring an additional 30,234 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after acquiring an additional 10,146 shares in the last quarter. Finally, Worth Asset Management LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% in the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after acquiring an additional 5,190 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Performance

NYSEARCA BTAL traded up $0.05 on Friday, reaching $11.86. The company’s stock had a trading volume of 198,359 shares, compared to its average volume of 822,117. AGF U.S. Market Neutral Anti-Beta Fund has a twelve month low of $10.86 and a twelve month high of $17.36. The stock has a market cap of $298.87 million, a PE ratio of 17.67 and a beta of -0.64. The firm’s 50 day moving average is $11.71 and its two-hundred day moving average is $12.74.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.